Congenital cytomegalovirus (CMV) is frequently associated with active retinitis. In contrast, in the immunocompetent neonate with postnatally acquired CMV infection retinitis is rarely present and usually does not progress. We describe the case of an infant with postnatal CMV infection and active retinitis diagnosed at 20 days of life. Owing to the rapid progression of the retinitis, therapy with intravenous ganciclovir was performed, with prompt regression of the retinitis. Therapy was then continued with oral valganciclovir for one further week. Although very unusual, CMV retinitis has to be taken into consideration in neonates with early postnatally acquired CMV infection, as an early diagnosis and treatment may be crucial to avoid visual impairment.
Introduction
Cytomegalovirus (CMV) infection in the neonatal period can occur either in utero (congenital infection) or in the postnatal age. Postnatal infection can be transmitted through vaginal secretions, contact with infected individuals excreting virus, blood transfusions, or most commonly via breast milk. 1 Usually the course of the disease in term neonates is asymptomatic, whereas in prematures or in immunocompromised infants the disease can lead to a broad spectrum of symptoms, including potentially life-threatening disease. 2 We report the case of postnatal CMV infection in a term neonate. The baby presented with anemia and active retinitis, which showed rapid improvement under antiviral therapy. His neurodevelopmental and ocular follow-up until 6 months is also described.
Case
A baby boy was spontaneously delivered by a 30-year-old gravida 1, para 0 woman at 38 weeks gestational age after an uneventful pregnancy. Birth weight was 2850 g, body length 48 cm and head circumference 34 cm, and Apgar scores were 9 and 10 at 1 and 5 min, respectively. Neonatal course was normal, but the infant was hospitalized at age 20 days for anemia, poor feeding and failure to thrive. Because of the anemia he received a red blood cell transfusion. Blood loss and hemolysis were excluded as the cause of the anemia. CMV DNA in urine was positive. Because of the CMV infection at age 28 days an eye examination was performed, showing retinal hemorrhages and retinal detachment in the left eye. At age 34 days, the baby was referred to our Unit to further investigate the ocular pathology and its relation with CMV infection.
On admission in our Unit the infant presented in a deteriorated general condition, poorly feeding, vomiting, and with moderate hepatosplenomegaly and retinal detachment in the left eye. Table 1 summarizes clinical, radiological and laboratory data.
Maternal serological tests disclosed high-avidity immunoglobulin (Ig)G, but no IgM, antibodies against CMV; urine tests (shell vial culture) showed no active infection. Tests for antibodies against Toxoplasma, Rubella and Herpes virus 1 and 2 were negative. The baby had not breast-fed.
At age 34 days, an active CMV infection in the baby was confirmed by virus isolation from urine and positive CMV DNA in saliva, whole blood and plasma. No CMV DNA was isolated from the cerebrospinal fluid. To identify the timing of CMV infection, the CMV DNA analysis was performed retrospectively on 40-ml of dried blood spot (DBS) of the neonatal screening card obtained at 3 days of life. The extraction of DBS was performed using the biorobot EZ1 DSP and the DNA tissue-kit (Qiagen, Hilden, Germany). CMV DNA analysis was performed using the artusCMV TM PCR kit (Qiagen) according to the TaqMan real-time PCR technique and using the ABI PRISM 7900 Sequence Detection System (Applied Biosystem, Foster City, CA, USA). No CMV DNA was detected, confirming the postnatal timing of the infection.
As the diagnostic work-up showed active retinitis associated with CMV infection, at age 37 days intravenous (i.v.) therapy was started with 10 mg kg À1 per day ganciclovir. Eye examination at age 39 days showed complete retinal detachment in the left eye and several Active retinitis in an infant
retinal hemorrhages in the right eye ( Figure 1 ). An ocular magnetic resonance imaging scan and an ultrasound scan confirmed subretinal and intravitreal hemorrhages in the right eye and complete retinal detachment, with exudates and vitreitis in the left eye. Other causes of retinitis were excluded. Two weeks later, the hemorrhage and exudation in both the eyes began to resolve. After 3 weeks, when eye examination showed initial scarring in the left eye and resolution of the lesions in the right eye, i.v. therapy was stopped. CMV DNA load performed in whole blood the same day of the eye examination was negative. Therapy was continued with oral valganciclovir 30 mg kg À1 per day for 1 week further. CMV DNA load in whole blood was repeated after discontinuation of the therapy (at age 72 days), with negative results. A visual-evoked potential study performed at 5 months of life showed left prechiasmatic visual pathway impairment and electroretinography yielded normal findings. Neurological and developmental evaluations performed at discharge and at 6 months of age showed mild abnormalities in muscle tone, for which motor physiotherapy was started. The auditory brain stem response showed normal findings.
Discussion
We describe the case of a neonate with active retinitis diagnosed at 20 days of life, in whom active CMV infection was proven. It can be difficult to distinguish between congenital and postnatal CMV infection when postnatal infection occurs in the first weeks of life. In fact, the isolation of CMV in a sample of blood or urine obtained later than 2 weeks after birth can not distinguish a congenitally from a postnatally acquired infection if there is no evidence of a maternal seroconversion. Nevertheless, CMV DNA extraction from the Guthrie cards can help in ascertaining whether a baby was congenitally infected or not. 3 Regarding the timing of infection, in the case we describe we excluded congenital CMV infection because of the result of maternal serology, and because of the negative result of CMV DNA amplification performed on the Guthrie card. The baby was not breast-fed, therefore, the most probable source of infection was horizontal transmission by an infected individual. As infection from a blood transfusion usually occurs at least 3 weeks later, the transfusion that the infant received at age 20 days clearly was not the source of his presenting symptoms.
Usually CMV retinitis does not progress after birth in the immunocompetent neonate. 4 In immunodeficient patients, such as patients with AIDS or in immunosuppressed patients it can progress rapidly and cause retinal detachment. 5, 6 However, even in immunocompromised children the occurrence of CMV retinitis after birth is very unusual, and only few cases have been reported. 7 Studies performed in humans and murine models suggest the role of the cell-mediated immune response in conditioning the MRI, magnetic resonance imaging; NBT, nitroblue tetrazolium test; Neut., neutrophils; PLT, platelets; US, ultrasound imaging; WBC, white blood cells.
Active retinitis in an infant F Piersigilli et al severity of CMV infection. Patients with cell-mediated immunodeficiency are at higher risk of developing CMV disease and T-cell-deficient nude mice are more susceptible to murine CMV infection. 8 A loss of T-cell function can also lead to reactivation and dissemination of CMV infection. 9 In our patient, despite his immunocompetent status, a serious retinitis was associated with an early postnatally acquired CMV infection.
Controversy exists on the necessity of treating CMV retinitis with antiviral therapy, as some cases of spontaneous resolution without therapy have been reported. 10 The antiviral drug most frequently used is ganciclovir; several side effects have been described in neonates, the most frequent being neutropenia. We decided to treat the baby because of the rapid progression of the retinitis. We obtained a dramatic improvement without any side effect. After 3 weeks, we decided to shift to oral therapy until complete resolution of the retinitis, which occurred 1 week later. We were able to stop therapy after 4 weeks.
Conclusion
The report of this severe case of retinitis underlines that, although an exceptional event, retinitis should be suspected even in neonates with acquired CMV infection. An early diagnosis and prompt therapy may be crucial to avoid visual impairment. Active retinitis in an infant
